LANGaware Awarded Patient Engagement Solutions Agreement With Premier, Inc. for Early Detection of Cognitive and Behavioral Health Diseases
LANGaware Awarded Patient Engagement Solutions Agreement With Premier, Inc. for Early Detection of Cognitive and Behavioral Health Diseases
NEW YORK, July 17, 2024 /PRNewswire/ -- LANGaware, a pioneering AI-driven healthcare technology company, has been awarded a national group purchasing agreement for Patient Engagement Solutions with Premier, Inc. Effective July 1st, 2024, the new agreement allows Premier members, at their discretion, access to LANGaware's advanced screening technology at special pricing and terms pre-negotiated by Premier.
LANGaware是一家具有开创性的人工智能驱动的医疗保健技术公司,在2024年7月1日获得了国家组购协议,提供患者参与解决方案。新的协议允许Premier的会员根据自己的意愿以特价和条款获得LANGaware先进的筛选技术。
LANGaware utilizes AI to predict and monitor neurodegenerative and behavioral health conditions such as Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD), and Depression. By analyzing digital biomarkers based on language, voice, and speech, LANGaware's platform offers unmatched accuracy in early detection, leading to improved patient outcomes, enhanced quality of life, and reduced healthcare costs. The integration of LANGaware's technology can help providers reduce costs through enhanced early diagnosis and timely interventions, while also driving revenue by offering a new billable service and improving patient satisfaction with accurate and efficient assessments.
LANGaware利用人工智能技术预测和监测神经退行性和行为健康状况,如轻度认知损害(MCI),阿尔茨海默病(AD)和抑郁症。通过分析基于语言、语音和言语的数字生物标志物,LANGaware的平台提供了无与伦比的早期检测精度,从而改善了患者的预后,提高了生活质量,降低了医疗保健成本。LANGaware技术的整合可以帮助供应商通过提供新的可计费服务和改进精确和高效的评估来减少成本,并通过增强早期诊断和及时干预来推动收入。
Developed through years of rigorous research and testing, LANGaware's patented technology is transforming early cognitive and behavioral health disease detection. By minimizing the risk of misdiagnosis and unnecessary treatments, LANGaware provides healthcare providers with a powerful tool for early detection, personalized support, and treatment monitoring.
LANGaware通过多年的严格研究和测试开发了自己的专利技术,改变了早期认知和行为健康疾病的检测。通过最小化误诊和不必要治疗的风险,LANGaware为医疗保健提供者提供了一种早期检测、个性化支持和治疗监测的强大工具。
"We are thrilled to join Premier's network and extend our digital assessment tool's reach to more patients, hospitals, and providers," said Vassiliki Rentoumi, Founder and CEO of LANGaware. "Our goal is to revolutionize early diagnosis, improve patient outcomes, and drive positive changes in the healthcare industry."
LANGaware的创始人兼首席执行官Vassiliki Rentoumi表示:“我们很高兴加入Premier网络,并扩大我们的数字评估工具对更多患者、医院和服务提供商的覆盖范围。我们的目标是改革早期诊断,改善患者预后,并推动医疗保健行业的积极变革。”
This collaboration marks a significant step forward in expanding access to advanced diagnostic services across the United States. Combining Premier's extensive member network with LANGaware's cutting-edge technology aims to revolutionize healthcare through innovative solutions.
此次合作标志着在美国扩大先进诊断服务的重要一步。将Premier的广泛会员网络与LANGaware的尖端技术相结合,旨在通过创新解决方案改革医疗保健领域。
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,350 U.S. hospitals and 300,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.
Premier是一个领先的医疗保健改进公司,联合了约4,350个美国医院和300,000名其他提供者,以改革医疗保健。通过集成数据和分析、协作、供应链解决方案、咨询等服务,Premier能够在降低成本的同时提供更好的护理和预后。
LANGaware leverages AI technology to revolutionize cognitive and behavioral health screening. By utilizing speech analysis and proprietary voice and speech biomarkers, LANGaware provides early, accurate and objective detection of conditions, enabling more effective treatments, reducing healthcare burdens, and improving overall well-being. For more information about LANGaware, please visit .
LANGaware利用人工智能技术来改变认知和行为健康筛查。通过利用语音分析和专有的声音和语音生物标志物,LANGaware提供了早期、准确和客观的疾病检测,从而实现更有效的治疗,减轻医疗负担,提高整体幸福感。有关LANGaware的更多信息,请访问。
Media Contacts:
Virginia Korma
646-878-9063
[email protected]
媒体联系人:
Virginia Korma
646-878-9063
[email protected]
SOURCE LANGaware
LANGaware资源